2019•Annals of Translational MedicineOpen access

Does impaired processing of pro-B-type (or brain) natriuretic peptide cause decreased plasma BNP levels in obese heart failure patients?

Toshio Nishikimi, Yasuaki Nakagawa

Abstract

The natriuretic peptide system consists of three distinct endogenous peptides: atrial natriuretic peptide (ANP), brain (or B-type) natriuretic peptide (BNP), and C-type natriuretic peptide (CNP), as well as three receptors: natriuretic peptide receptor-A (NPR-A or guanynyl cyclase-A), natriuretic peptide receptor-B (NPR-B or guanynyl cyclase-B) and natriuretic peptide receptor-C (NPR-C or clearance receptor) (1). ANP and BNP are cardiac hormones, with ANP produced mainly in the atria and BNP produced mainly in the ventricles.

Open-access reader

About this research paper

What this paper is about

Why it matters

OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: NPR2, NPR1, Natriuretic peptide, Internal medicine, Endocrinology, Receptor, Brain natriuretic peptide, Atrial natriuretic peptide